Chesapeake Wealth Management United Therapeutics Corp Transaction History

Chesapeake Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$174.81 - $241.14 $328,642 - $453,343	-1,880 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$166.16 - $213.96 $406,593 - $523,560	-2,447 Reduced 56.55%	1,880 $338,000
Q4 2021 Feb 03, 2022	BUY	$184.32 - $216.08 $32,256 - $37,814	175 Added 4.21%	4,327 $935,000
Q3 2021 Oct 26, 2021	SELL	$179.86 - $214.88 $11,690 - $13,967	-65 Reduced 1.54%	4,152 $766,000
Q2 2021 Jul 29, 2021	BUY	$170.47 - $211.93 $96,656 - $120,164	567 Added 15.53%	4,217 $757,000
Q1 2021 Apr 26, 2021	BUY	$153.94 - $174.85 $561,881 - $638,202	3,650 New	3,650 $610,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Chesapeake Wealth Management with notifications on news.